Glaucoma specialists share insights into treating uveitis-glaucoma-hyphema (UGH) syndrome, as featured in the January/February 2026 issue of Glaucoma Today. Roya Garakani, DO, recaps, “Surgical Decision-Making in Patients With UGH Syndrome,” outlining options for patients with UGH syndrome who require glaucoma surgery in addition to an IOL procedure. Then, Mahsaw Mansoor, MD, recaps, “Selecting an IOL and Fixation Technique for Patients With UGH Syndrome,” which was written with Nicole Fram, MD, and presents a case-based approach to surgical management of in-the-bag UGH syndrome secondary to dead bag syndrome.

Welcome to GT: The Podcast! In this episode, glaucoma specialists share the approaches and pearls they wish they had discovered sooner, as featured in the November/December 2025 issue of Glaucoma Today. Kateki Vinod, MD, and Won I. Kim, MD, share their reflections on IOP monitoring and how home tonometry has changed their respective practices. Later, Jenny Lu describes age-related neuroretinal alterations and how these changes can mimic glaucomatous damage, as covered in an article by Shuning Li, MD, PhD, and Ying Han, MD, PhD.

Welcome to GT: The Podcast! In this episode, Chelvin Sng, BA, MA, MBBChir, MMed, MRCS(Ed), FRCS(Ed), FAMS, recaps her article, “The Paul Glaucoma Implant,” which was featured in the November/December issue of Glaucoma Today. The Paul Glaucoma Implant (Advanced Ophthalmic Innovations) is a glaucoma drainage device designed to fulfill the unmet need for a tube shunt with greater efficacy but a lower risk of hypotony. Dr. Sng reviews device characteristics, surgical technique, postoperative management, and clinical data.

Welcome to GT: The Podcast! In this episode, Mohamed M. Khodeiry, MD, MSc, recaps his article, “Glaucoma Intrascleral Tube Surgery,” written with James Richardson-May, MD, and Ahmed Elbably, MSc, FRCS, and featured in the July/August issue of Glaucoma Today. A surgical modification called glaucoma intrascleral tube surgery (GITS) may help address some postoperative complications associated with subconjunctival stent implantation. Dr. Khodeiry discusses the development of GITS, specifics of the surgical technique, early outcomes, and future directions.

Rachel Chapman recaps her article, “Tube Erosion,” which was written with Matthew Henderson, MD; Dan Arreaza-Kaufman, MD; Jonathan Eisengart, MD; and Mary Qiu, MD, and was featured in the May/June issue of Glaucoma Today. Glaucoma drainage implants can lower IOP and preserve patients’ vision, but the devices carry the risk of tube erosion, a serious complication that requires prompt surgical management. Ms. Chapman reviews the rates of tube erosion, risk factors, strategies for prevention, and techniques for surgical revision.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS. Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is. Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of GT’s audience.

Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of Glaucoma Today. Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes.

I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. Editorially independent content supported with advertising by Glaukos.

Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of Glaucoma Today and explores a novel class of glaucoma surgery that targets the supraciliary space. The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.